Abstract:The immune response holds a pivotal role in cardiovascular disease development. As multifunctional cells of the innate immune system, macrophages play an essential role in initial inflammatory response that occurs following cardiovascular injury, thereby inducing subsequent damage while also facilitating recovery. Meanwhile, the diverse phenotypes and phenotypic alterations of macrophages strongly associate with distinct types and severity of cardiovascular diseases, including coronary heart disease, valvular disease, myocarditis, cardiomyopathy, heart failure, atherosclerosis and aneurysm, which underscores the importance of investigating macrophage regulatory mechanisms within the context of specific diseases. Besides, recent strides in single-cell sequencing technologies have revealed macrophage heterogeneity, cell–cell interactions, and downstream mechanisms of therapeutic targets at a higher resolution, which brings new perspectives into macrophage-mediated mechanisms and potential therapeutic targets in cardiovascular diseases. Remarkably, myocardial fibrosis, a prevalent characteristic in most cardiac diseases, remains a formidable clinical challenge, necessitating a profound investigation into the impact of macrophages on myocardial fibrosis within the context of cardiac diseases. In this review, we systematically summarize the diverse phenotypic and functional plasticity of macrophages in regulatory mechanisms of cardiovascular diseases and unprecedented insights introduced by single-cell sequencing technologies, with a focus on different causes and characteristics of diseases, especially the relationship between inflammation and fibrosis in cardiac diseases (myocardial infarction, pressure overload, myocarditis, dilated cardiomyopathy, diabetic cardiomyopathy and cardiac aging) and the relationship between inflammation and vascular injury in vascular diseases (atherosclerosis and aneurysm). Finally, we also highlight the preclinical/clinical macrophage targeting strategies and translational implications.

Cardiac resident macrophages: Spatiotemporal distribution, development, physiological functions, and their translational potential on cardiac diseases

Spatiotemporal development and the regulatory mechanisms of cardiac resident macrophages: Contribution in cardiac development and steady state

Resident macrophages as potential therapeutic targets for cardiac ageing and injury

Cardiac resident macrophages: The core of cardiac immune homeostasis

The Roles of Macrophages in Heart Regeneration and Repair after Injury

Distinct Origins and Functions of Cardiac Orthotopic Macrophages

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

At the heart of inflammation: Unravelling cardiac resident macrophage biology

The role of cardiac resident macrophage in cardiac aging

Transcriptomic profiling and regulatory pathways of cardiac resident macrophages in aging

Renewal of embryonic and neonatal-derived cardiac-resident macrophages in response to environmental cues abrogated their potential to promote cardiomyocyte proliferation via Jagged-1–Notch1

The Evolving Roles of Cardiac Macrophages in Homeostasis, Regeneration, and Repair

The Characteristic of Resident Macrophages and Their Therapeutic Potential for Myocardial Infarction

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases

Macrophages in cardiac homeostasis, injury responses and progenitor cell mobilisation

Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis

Dissecting and Visualizing the Functional Diversity of Cardiac Macrophages

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

Macrophage-driven Cardiac Inflammation and Healing: Insights from Homeostasis and Myocardial Infarction

Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction